Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. Keeping that in mind, here are three value stocks with little support and some other investments you should consider instead.
Zimmer Biomet (ZBH)
Forward P/E Ratio: 10.8x
With a history dating back to 1927 and a presence in over 100 countries worldwide, Zimmer Biomet (NYSE:ZBH) designs and manufactures orthopedic products including knee and hip replacements, surgical tools, and robotic technologies for joint reconstruction and spine surgeries.
Why Do We Think Twice About ZBH?
- 4.5% annual revenue growth over the last five years was slower than its healthcare peers
- Estimated sales growth of 3.9% for the next 12 months implies demand will slow from its two-year trend
- Low returns on capital reflect management’s struggle to allocate funds effectively
At $90.26 per share, Zimmer Biomet trades at 10.8x forward P/E. To fully understand why you should be careful with ZBH, check out our full research report (it’s free).
Renasant (RNST)
Forward P/B Ratio: 0.8x
Founded in 1904 during a time when the South was rebuilding its economy, Renasant (NYSE:RNST) is a regional bank holding company that offers banking, wealth management, insurance, and specialized lending services throughout the Southeast.
Why Are We Wary of RNST?
- 8.1% annual revenue growth over the last five years was slower than its banking peers
- Incremental sales over the last two years were much less profitable as its earnings per share fell by 2.1% annually while its revenue grew
- 3.7% annual tangible book value per share growth over the last two years was slower than its banking peers
Renasant’s stock price of $37.03 implies a valuation ratio of 0.8x forward P/B. Dive into our free research report to see why there are better opportunities than RNST.
Eastern Bank (EBC)
Forward P/B Ratio: 1x
Founded in 1818 as one of America's oldest mutual banks before converting to a public company in 2020, Eastern Bankshares (NASDAQ:EBC) operates as a bank holding company providing commercial and retail banking services primarily in Massachusetts, New Hampshire, and Rhode Island.
Why Does EBC Worry Us?
- Products and services are facing significant credit quality challenges during this cycle as tangible book value per share has declined by 5.2% annually over the last five years
- Anticipated tangible book value per share growth of 2.1% for the next year implies profitability will be modest
- ROE of 2.7% reflects management’s challenges in identifying attractive investment opportunities
Eastern Bank is trading at $19.86 per share, or 1x forward P/B. Read our free research report to see why you should think twice about including EBC in your portfolio.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.